| Spatial mapping of mitochondrial networks and bioenergetics in lung cancer M Han, EA Bushong, M Segawa, A Tiard, A Wong, MR Brady, ... Nature 615 (7953), 712-719, 2023 | 38 | 2023 |
| Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency M Han, CE Napier, S Frölich, E Teber, T Wong, JR Noble, EHY Choi, ... Journal of Cell Science 132 (5), jcs222349, 2019 | 24 | 2019 |
| LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer CW Murray, JJ Brady, M Han, H Cai, MK Tsai, SE Pierce, R Cheng, ... Nature communications 13 (1), 1090, 2022 | 9 | 2022 |
| Diversity of mitochondrial networks in lung cancer imaged DB Shackelford, M Han Annu. Rev. Biophys. Biomol. Struct 35, 199-224, 2023 | | 2023 |
| In vivo imaging of mitochondrial bioenergetics in lung cancer M Han, M Momcilovic, E Bushong, L Stiles, O Shirihai, C Koehler, ... Cancer Research 81 (13_Supplement), 2818-2818, 2021 | | 2021 |
| IA08 Mapping Mitochondrial Heterogeneity in Lung Cancer M Momcilovic, M Han, E Bushong, L Stiles, SM Dubinett, H Christofk, ... Journal of Thoracic Oncology 15 (2), S4, 2020 | | 2020 |
| Abstract A22: Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency M Han, CE Napier, S Frölich, RD Everett, AJ Cesare, RR Reddel Molecular Cancer Therapeutics 16 (10_Supplement), A22-A22, 2017 | | 2017 |
| CAN ATRX DEFICIENCY BE EXPLOITED FOR ANTI-CANCER THERAPY? M Han, CE Napier, RD Everett, RR Reddel ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 10, 15-15, 2014 | | 2014 |
